Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and azathioprine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with azathioprine in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(azathioprine)
Trials
(azathioprine)
Recent Studies (post-2010) (azathioprine)
9,15618755215,4891,7463,080

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braquet, P; Foegh, ML; Khirabadi, BS; Ramwell, PW; Rowles, JR2

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and azathioprine

ArticleYear
Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor.
    Transplantation, 1986, Volume: 42, Issue:1

    Topics: Animals; Azathioprine; Cyclosporins; Diterpenes; Ginkgolides; Graft Rejection; Graft Survival; Heart Transplantation; Immunity, Cellular; Lactones; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous

1986
The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats.
    Pharmacological research communications, 1986, Volume: 18 Suppl

    Topics: Animals; Azathioprine; Graft Rejection; Heart Transplantation; Platelet Activating Factor; Rats; SRS-A

1986